Jenburkt Pharmaceuticals Ltd — Important, 07-05-2026: Company Update

Jenburkt Pharmaceuticals' Annual Secretarial Compliance Report for the financial year ending March 2026 indicates overall adherence to regulations. However, it noted a few technical non-compliances. Past financial results for the quarter and year ended March 2025, and the financial results for the quarter and half-year ended September 2025, were initially filed on time. Subsequent revisions requested by the exchange led to the system logging these as delayed. Additionally, the Audit Committee Chairperson was absent from the Annual General Meeting due to travel, a technical lapse in governance. The company is taking steps to ensure strict compliance going forward.